About
Michael Berman is a medical device investor and entrepreneur who has co-founded and led several companies in the sector. He co-founded Velocimed, which sold to St. Jude Medical in 2005 for $82.5M, and later co-founded and chaired both BridgePoint Medical (sold to Boston Scientific) and Rebiotix (sold to Ferring Pharmaceuticals). Earlier in his career he served as President of the Cardiology business at Boston Scientific from 1995 to 2000. He currently serves on the boards of 11 emerging medical device companies and holds BS and MBA degrees from Cornell University.
ContactΒ· published on Mike's own website
Invests in
Medical Devices
Beyond investing
- Founded
- Co-founded Velocimed, which was sold to St. Jude Medical in April 2005 for $82.5M. Co-founded and chaired BridgePoint Medical from 2005 to 2012, when it was sold to Boston Scientific. Co-founded and chaired Rebiotix from 2011 to 2018, when it was sold to Ferring Pharmaceuticals.
- Education
- Earned a BS from Cornell University in 1979. Earned an MBA from Cornell University in 1986.
From Mike's own website β common ground for a warm intro.
Experience
- RiverVest VenturesVenture Partnercurrent2014 β present
- Multiple Medical Device CompaniesBoard Membercurrent2000 β present
- RebiotixChairman2011 β 2018
- Boston Scientific CardiologyPresident1995 β 2000
Skills & more
+12 more
Quality AssuranceProduct LaunchDesign ControlBiotechnologyAngel InvestingCardiologyBusiness StrategyFDAManagementEntrepreneurshipCross-functional Team LeadershipLifesciencesFrom Mike's professional profile.
Investments
Board seats
CardiacSenseCardiosonicClearCut MedicalKedma SolarLutonixLutonix, Inc.Mazor RoboticsSTStentUltraShape inc.VenaCore/ToTAL
Investor
Velocimed, LLC
Sources: the investor's own website Β· the firm's website.
Colleagues at RiverVest Venture Partners
Frequently asked questions
- Who is Mike Berman?
- Michael Berman is a medical device investor and entrepreneur who has co-founded and led several companies in the sector. He co-founded Velocimed, which sold to St. Jude Medical in 2005 for $82.5M, and later co-founded and chaired both BridgePoint Medical (sold to Boston Scientific) and Rebiotix (sold to Ferring Pharmaceuticals). Earlier in his career he served as President of the Cardiology business at Boston Scientific from 1995 to 2000. He currently serves on the boards of 11 emerging medical device companies and holds BS and MBA degrees from Cornell University.
- Where does Mike Berman work?
- Mike Berman is Consultant and Venture Partner at RiverVest Venture Partners.
- What does Mike Berman invest in?
- Mike Berman invests in Medical Devices.
- What boards does Mike Berman sit on?
- Mike Berman holds tracked board seats at CardiacSense, Cardiosonic, ClearCut Medical, Kedma Solar, Lutonix, Lutonix, Inc., Mazor Robotics, STStent, UltraShape inc., VenaCore/ToTAL.
- What companies has Mike Berman invested in?
- Investments tracked here include Velocimed, LLC.
- Where did Mike Berman go to school?
- Mike Berman studied at Cornell University (MBA, Marketing).
Same school
Also attended Cornell University914
+ 908 more








